Kwality Pharma Gets EU-GMP Approval from Hungary

Kwality Pharmaceuticals Ltd. has received EU-GMP approval from Hungary for its Cephalosporin and Oncology facilities. This complements their existing EU-GMP approval from Bulgaria, significantly expanding their manufacturing capabilities in specialized pharmaceutical segments. The approval is expected to enhance their competitive position in highly regulated markets, attract new licensing opportunities, accelerate product registrations, and improve competitiveness in high-value global markets. This milestone is a key step in expanding the company's international footprint and driving sustainable business growth.